You are here: Industry Insights > warning

News List

Emcure Pharmaceuticals receives warning letter from FDA europeanpharmaceuticalreview
August 21, 2019
A warning letter has been sent to Emcure Pharmaceuticals after an FDA facility inspection found that the company did not adequately investigate sterility failures.
Teva shares approach 20-year low amid Moody's warning and other woes fiercepharma
August 18, 2019
Teva Pharmaceutical CEO Kåre Schultz has gone to great lengths to shave off $3 billion in costs by instituting a major restructuring plan that has included slashing 14,000 jobs and shuttering manufacturing plants around the world.
FDA Sending Warning to Curaleaf for Marketing Unapproved Cannabidiol Products americanpharmaceuticalreview
July 26, 2019
The U.S. Food and Drug Administration (FDA) has issued a warning letter to Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products containing cannabidiol (CBD) online with ...
FDA issues three warning letters to API re-packers europeanpharmaceuticalreview
July 04, 2019
Three API re-packers who failed to meet current good manufacturing practice requirements have received warning letters from the FDA.
Sugary Sodas Still Popular, But Warnings, Taxes Can Curb Uptake drugs
June 10, 2019
Sugary Sodas Still Popular, But Warnings, Taxes Can Curb Uptake.
FDA pushes for stronger warnings on insomnia medicines pharmatimes
May 10, 2019
FDA pushes for stronger warnings on insomnia medicines.
FDA warning slams St Jude's "inadequate response" to device failures pharmafile
April 14, 2017
St Jude Medical has been hit with a warning letter from the FDA over the medical device manufacturer’s failure to address issues with its implantable defibrillators and at-home monitoring equipment.